Parmax Pharma Ltd share price logo

Parmax Pharma Ltd

BSE: 540359

Small Cap

Pharma Sector

₹32.10

-0.39

(-1.20%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Parmax Pharma Stock Performance

as on May 7, 2026 at 5:14 pm IST

  • ₹32.10
    ₹32.10

  • 52 Week's Low

    52 Week's High

    ₹22.60
    ₹53.46
    downward going graph

    29.60%

    Downside

    66.54%

    Upside

    downward going graph

Parmax Pharma share price movements today

Previous Close
₹32.49
Open
₹32.10
Volume
200.00
Upper Circuit
₹38.98
Lower Circuit
₹26.00
Day's Low - High
₹32.10 - ₹32.10
52 Week Low - High
₹22.60 - ₹53.46

Parmax Pharma Historical Returns

1 Month Return
+ 5.11 %
3 Month Return
-0.21 %
1 Year Return
-30.62 %
3 Year Return
+ 5.25 %
5 Year Return
-46.65 %

Parmax Pharma Fundamentals

as on May 7, 2026 at 11:44 am IST

Market Cap

₹12.16 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

-0.21

P/B Ratio

-9.45

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

87.18

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Parmax Pharma Technical Analysis

Track how Parmax Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish6
Neutral7

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
-66.67
Neutral
RSI (14)
28.49
Bullish
Momentum (10)
0
Neutral
ADI (14)
43.2
Neutral
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
32.1
Neutral
EMA (20)
32.1
Bearish
VWMA (20)
32.1
Neutral
SMA (50)
32.1
Neutral
EMA (50)
32.1
Bullish
SMA (200)
31.72
Bullish
EMA (200)
31.93
Bullish
KAMA (200)
32.1
Neutral
DEMA (200)
32.06
Bullish

Parmax Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Parmax Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Parmax Pharma Ltd image
Parmax Pharma Ltd
NA12.16-9.33%0.00-328
Jenburkt Pharmaceuticals Ltd image
Jenburkt Pharmaceuticals Ltd
BUY507.9331.05%0.0032151
Wockhardt Ltd image
Wockhardt Ltd
NA27,898.2845%0.68-573,012
Pfizer Ltd image
Pfizer Ltd
BUY21,882.06-2.08%0.00NANA
Novelix Pharmaceuticals Ltd image
Novelix Pharmaceuticals Ltd
NA115.9994.13%0.00-130
See all

Parmax Pharma Stock’s Investor Sentiment and Interest

Search interest for Parmax Pharma Ltd Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:17% versus previous 30 day period

Parmax Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1.4
4.07
1.33
4.26
7.82
9.28
6.28
4.83
1.94
2.53
4.33
Other Income
0.01
0.01
0.01
0.01
0.01
0.12
0.01
-0.1
0.01
0.01
0.01
Total Income
1.41
4.08
1.34
4.27
7.82
9.39
6.3
4.73
1.95
2.54
4.33
Expenses
2.05
4.83
2.48
5.06
7.3
9.08
6.18
6.46
2.19
4.12
4.52
Operating Profit
-0.65
-0.76
-1.15
-0.8
0.52
0.2
0.1
-1.63
-0.25
-1.59
-0.19
Operating Profit Margin %
-46.43%
-18.67%
-86.47%
-18.78%
6.65%
2.16%
1.59%
-33.75%
-12.89%
-62.85%
-4.39%
Profit Before Interest, Tax and Depreciation
-0.64
-0.75
-1.14
-0.79
0.52
0.32
0.12
-1.74
-0.24
-1.58
-0.19
Interest
0.12
0.18
0.16
0.16
0.11
0.13
0.11
0.24
0.28
0.24
0.28
Depreciation
0.42
0.43
0.45
0.41
0.4
0.4
0.41
-0.18
0.24
0.26
0.27
Profit Before Tax
-1.18
-1.36
-1.75
-1.36
0.01
-0.21
-0.4
-1.8
-0.76
-2.08
-0.74
Tax Paid
-
-
-
0.09
-
-
-
-0.3
-
-
-
Profit After Tax
-1.18
-1.37
-1.75
-1.45
0.01
-0.22
-0.39
-1.49
-0.76
-2.08
-0.73
Total Net profit including share of profit / Loss from associate company
-1.18
-1.37
-1.75
-1.45
0.01
-0.22
-0.39
-1.49
-0.76
-2.08
-0.73
EPS
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
-1.96
Actual EPS
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
-1.96
Adjusted EPS
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
-1.96
Diluted EPS
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
-1.96

Parmax Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
11.9
12.01
20.93
26.2
18.25
15.42
11.05
28.2
Other Income
0.05
0.05
0.1
0.09
0.06
0.04
0.05
0.04
Total Income
11.95
12.06
21.03
26.29
18.31
15.46
11.1
28.24
Expenses
10.82
10.9
19.17
22.79
15.69
13.17
14.42
29.02
Operating Profit
1.08
1.11
1.76
3.41
2.56
2.25
-3.37
-0.82
Operating Profit Margin %
9.08%
9.24%
8.41%
13.02%
14.03%
14.59%
-30.5%
-2.91%
Profit Before Interest, Tax and Depreciation
1.13
1.16
1.87
3.5
2.62
2.29
-3.32
-0.78
Interest
0.03
0.03
0.13
0.35
0.39
0.37
0.62
0.59
Depreciation
1.09
1.03
1.01
1.94
1.93
1.88
1.71
1.03
Profit Before Tax
0.01
0.1
0.73
1.21
0.3
0.04
-5.65
-2.4
Tax Paid
0.01
0.02
0.3
0.46
0.17
0.16
0.09
-0.3
Profit After Tax
-
0.08
0.43
0.75
0.14
-0.1
-5.75
-2.09
Total Net profit including share of profit / Loss from associate company
-
0.08
0.43
0.75
0.14
-0.1
-5.75
-2.09
EPS
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6
Actual EPS
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6
Adjusted EPS
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6
Diluted EPS
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6

Parmax Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-
-0.5
3.88
0.92
2.82
3.53
0.75
0.33
-0.2
-0.96
Cash Flow from Investing Activities
-
-0.19
-4.23
-3.41
-2.4
-3.15
-1.53
-0.94
-1.59
-0.7
Cash Flow from Financing Activities
0.09
0.56
1.14
3.1
-0.23
0.4
-0.91
-0.04
1.43
1.4
Net Cash Flow
0.09
-0.14
0.79
0.61
0.2
0.78
-1.69
-0.65
-0.36
-0.26

Parmax Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
30.8%
30.8%
30.8%
30.83%
30.8%
30.8%
30.8%
30.8%
30.8%
30.8%
30.8%
30.8%
Public
69.2%
69.2%
69.2%
69.17%
69.2%
69.2%
69.2%
69.2%
69.2%
69.2%
69.2%
69.2%
Total Outstanding Shares
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
Total Shareholders
1,978
1,973
2,002
2,099
2,185
2,246
2,334
2,356
2,377
2,399
2,393
2,388

Parmax Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Parmax Pharma.

  • Parmax Pharma Ltd Earnings Results

    Parmax Pharma Ltd’s net profit fell -87.18% since last year same period to ₹0.73Cr in the Q3 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 64.9% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Parmax Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Parmax Pharma stock has moved up by 8.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 233.5% return, outperforming this stock by 228.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.4% return, outperforming this stock by 63.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 30.80% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 69.20% of holdings in Mar 2026 quarter

About Parmax Pharma Ltd

Parmax Pharma PPL is a public limited company which was incorporated in November 1994 and promoted by Jayantilal S Dhol Purushottam J Bhalodi and Prabhudas D Hansalpara. It has set up a plant in Hadamtala Gujarat and has an installed capacity of 96 tonnes per annum for the production of bulk drugs such as amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid. Its Antibiotic project has been completely implemented since 31st May 1997 and its non Antibiotic products project is currently in its final stages of implementation.

Revenue: ₹4.33Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.73Cr as on December 2025 (Q3 FY26)
OrganisationParmax Pharma Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Parmax Pharma share price today?

Parmax Pharma share price today stands at ₹32.1 as on . Parmax Pharma share today touched a day high of ₹32.1 and a low of ₹32.1.

What is the 52 week high and 52 week low range for Parmax Pharma share?

Parmax Pharma touched a 52 week high of ₹53.46 and a 52 week low of ₹22.6. Parmax Pharma share price today i.e. is trending at ₹32.1, which is -39.96% down from its 52 week high and 42.04% up from its 52 week low.

What is Parmax Pharma's market capitalisation today?

Parmax Pharma market capitalisation is ₹12.16 Cr as on .

How to buy Parmax Pharma shares?

To buy Parmax Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 540359 or Parmax Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Parmax Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Parmax Pharma trading volume today?

Parmax Pharma trading volume is 200.00 as on . This means that 200.00 shares of Parmax Pharma were bought and sold on the stock market during today's trading session.